Durvalumab,Carboplatin,Paclitaxel,Cisplatin,Gemcitabine,Pemetrexed,Nivolumab,Ipilimumab,Vinorelbine,Docetaxel
Astrazeneca,bms
['lcsm,(-blcsm)', 'ts,perio,i', 'ts,perio,1', 'aegean', 'cm816']
#aacr23 is #aegean a practice-changing study by ? - with similar outcomes to cm816, aegean represents a new option of periop chemo-io + 1 yr io
- does not replace cm816
- does not address what adj io adds, therefore a lateral move on practice #lcsm 
Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct Professor Johns Hopkins University